ISEE - IVERIC bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
209,977
50,909
51,505
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
51,505
Operating Expenses
Research Development
44,205
41,737
66,289
196,295
131,012
Selling General and Administrative
21,020
23,612
35,683
50,178
44,021
Total Operating Expenses
65,225
65,349
101,972
246,473
175,033
Operating Income or Loss
-65,225
-65,349
108,005
-195,564
-123,528
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
125,152
124,984
-34
34
53
Income Before Tax
62,387
62,024
109,493
-193,826
-122,504
Income Tax Expense
-346
-1,063
-4,712
-406
-16,787
Income from Continuing Operations
62,733
63,087
114,205
-193,420
-105,717
Net Income
62,733
63,087
114,205
-193,420
-105,717
Net Income available to common shareholders
62,733
63,087
114,205
-193,420
-105,717
Reported EPS
Basic
-
1.70
3.18
-5.45
-3.06
Diluted
-
1.70
3.17
-5.45
-3.06
Weighted average shares outstanding
Basic
-
37,061
35,919
35,486
34,580
Diluted
-
37,088
36,007
35,486
34,580
EBITDA
-
-65,166
110,768
-194,807
-123,528